Zeo Scientifix, INC Form 4 insider transactions
OQB
Skycrest Holdings, LLC, a former 10% owner, reports purchasing additional shares of Zeo ScientifiX, Inc. common stock.
OQB
Skycrest Holdings, LLC, a former 10% owner, reports purchasing additional shares of Zeo ScientifiX, Inc. common stock.
OQB
Form 4: Skycrest Holdings, LLC Disposes of Series C Preferred Stock and Warrants in Zeo ScientifiX, Inc.
Skycrest Holdings, LLC, a 10% owner of Zeo ScientifiX, Inc., disposed of 50 shares of Series C Preferred stock and warrants to purchase 350,000 common shares.
OQB
Director Ian T. Bothwell of Zeo ScientifiX, Inc. engaged in transactions involving Series C Preferred stock on December 30, 2024.
OQB
Skycrest Holdings, LLC, a 10% owner of Zeo ScientifiX, Inc., acquired warrants to purchase 750,000 shares of common stock.
OQB
Zeo ScientifiX, Inc. reports a transaction where Skycrest Holdings, LLC acquired 266 shares of common stock at $3.02 per share.
OQB
Skycrest Holdings, a 10% owner of Zeo ScientifiX, has increased its holdings through open market purchases of common stock.
OQB
Skycrest Holdings, LLC, a 10% owner of Zeo ScientifiX, Inc., has increased its holdings through a series of open market purchases.
OQB
Skycrest Holdings, LLC, a 10% owner of Zeo ScientifiX, Inc., reports purchasing additional shares of common stock.
OQB
Wendy Grey, a director and 10% owner of Zeo ScientifiX, acquired warrants to purchase 350,000 shares of common stock.
OQB
Director Leathem S. Stearn reports the acquisition of stock options in Zeo ScientifiX, Inc.
OQB
Skycrest Holdings, LLC, a 10% owner and director of Zeo ScientifiX, Inc., acquired warrants to purchase 350,000 shares of common stock.
OQB
Dr. George Craig Shapiro, Chief Medical Officer of Zeo ScientifiX, Inc., was granted stock options for 125,000 shares on July 11, 2024.
OQB
Director Steven Jerry Glauser of Zeo ScientifiX, Inc. was granted stock options for 125,000 shares on July 11, 2024, according to a Form 4 filing.
OQB
Director Charles Luther Bretz reports acquisition of stock options in Zeo ScientifiX, Inc.
OQB
Ian T. Bothwell, Interim CEO & CFO of Zeo ScientifiX, Inc., reports the acquisition of stock options.
OQB
Director Gurvinder Pal Singh of Zeo ScientifiX, Inc. (ZEOX) was granted stock options on April 1, 2024.
OQB
Director Leathem S. Stearn reports acquisition of Zeo ScientifiX shares and stock options.
OQB
Director Steven Jerry Glauser reports acquisition of shares and stock options in Zeo ScientifiX, Inc.
OQB
Director Charles Luther Bretz reports the acquisition of stock options in Zeo ScientifiX, Inc.